Product Reports Resources Pricing Login Book a demo

ArcherDX

Biotech & Life Sciences · Boulder, United States · Founded 2013

Biotechnology firm specializing in cancer research MoreLess

ArcherDX is a biotechnology company that specializes in genomic analysis for cancer research. The company provides a range of products and services designed to be accurate, personalized, and actionable for use in local laboratories.

Their core offering includes kits and software that enable researchers and clinicians to conduct targeted sequencing with greater speed and precision. These tools are used to identify known and novel fusion transcripts, which are important in cancer diagnostics. ArcherDX's platform is intended to make precision oncology more accessible.

The company serves researchers and clinicians in the oncology field. Their business model is based on the sale of these kits and software. ArcherDX was acquired by Invitae, a move that is expected to create a global leader in comprehensive cancer genetics and precision oncology.

Keywords: genomic analysis, precision oncology, molecular diagnostics, cancer research, sequencing kits, bioinformatics software, targeted sequencing, fusion transcripts, cancer genetics, liquid biopsy

Valuation $1–2.5B
Revenue $50–100M
Headcount <100
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for ArcherDX and the history behind them.
Power Law Unicorn$1–10B valuation tier Colt$25–100M revenue

Talent graph

ArcherDX's talent

Book a demo to see the people
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on ArcherDX's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 4 investors entered at this stage
Boulder Ventures
PBM Capital Group
Perceptive Advisors
The Peierls Foundation
Series B+ 3 investors entered at this stage
Driehaus Capital Management
Redmile Group
ArrowMark Partners

Global footprint

Where ArcherDX has talent and traffic

Workforce by country
🇺🇸 United States · Boulder HQ
Book a demo for the full country breakdown
Web traffic by country
3.4K monthly visits
across markets
🇺🇸 United States79.4%
🇮🇳 India20.6%
🇮🇱 Israel2.9%
Top 3 markets shown

Patent intelligence

ArcherDX’s patent portfolio

Estimated portfolio value
$29M

11 active families in the valuation dataset.

Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.

Compare patent portfolios across companies →

Market sentiment

What the market is saying about ArcherDX

An AI-synthesized read of the highest-engagement posts about ArcherDX on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ArcherDX on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles